{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T02:06:29Z","timestamp":1791079589669,"version":"4.1.0"},"reference-count":26,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2004,5,1]],"date-time":"2004-05-01T00:00:00Z","timestamp":1083369600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Clinical Immunology"],"published-print":{"date-parts":[[2004,5]]},"DOI":"10.1016\/j.clim.2003.12.009","type":"journal-article","created":{"date-parts":[[2004,5,11]],"date-time":"2004-05-11T10:36:08Z","timestamp":1084271768000},"page":"202-209","source":"Crossref","is-referenced-by-count":8,"title":["A high-throughput proteo-genomics method to identify antibody targets associated with malignant disease"],"prefix":"10.1016","volume":"111","author":[{"given":"Yinyin","family":"Huang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph","family":"Franklin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kathreen","family":"Gifford","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bruce L","family":"Roberts","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charles A","family":"Nicolette","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.clim.2003.12.009_BIB1","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1186\/bcr326","article-title":"Update on HER-2 as a target for cancer therapy: herceptin in the clinical setting","volume":"3","author":"Miles","year":"2001","journal-title":"Breast Cancer Res."},{"key":"10.1016\/j.clim.2003.12.009_BIB2","first-page":"66","article-title":"Overview of the clinical development of rituximab: first monoclonal antibody approved for the treatment of lymphoma","volume":"26","author":"Grillo-L\u00f3pez","year":"1999","journal-title":"Semin. Oncol."},{"key":"10.1016\/j.clim.2003.12.009_BIB3","first-page":"125","article-title":"Epidermal growth factor receptor as a target for therapy with antireceptor monoclonal antibodies","volume":"13","author":"Mendelsohn","year":"1992","journal-title":"J. Natl. Cancer Inst. Monographs"},{"key":"10.1016\/j.clim.2003.12.009_BIB4","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1007\/s002620000126","article-title":"Immunological properties of a single-chain fragment of the anti-idiotypic antibody ACA125","volume":"49","author":"Reinartz","year":"2000","journal-title":"Cancer Immunol. Immunother."},{"key":"10.1016\/j.clim.2003.12.009_BIB5","doi-asserted-by":"crossref","first-page":"S13","DOI":"10.1007\/PL00014042","article-title":"Recombinant antibodies against ganglioside expressed on tumor cells","volume":"46","author":"Hanai","year":"2000","journal-title":"Cancer Chemother. Pharmacol."},{"key":"10.1016\/j.clim.2003.12.009_BIB6","first-page":"93","article-title":"Initial experience with high-dose radioimmunotherapy of metastatic medullary thyroid cancer using 131I-MN-14 F(ab)2 anti-carcinoembryonic antigen MAb and AHSCR","volume":"41","author":"Juweid","year":"2000","journal-title":"J. Nucl. Med."},{"key":"10.1016\/j.clim.2003.12.009_BIB7","doi-asserted-by":"crossref","first-page":"11810","DOI":"10.1073\/pnas.92.25.11810","article-title":"Human neoplasms elicit multiple specific immune responses in the autologous host","volume":"92","author":"Sahin","year":"1995","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.clim.2003.12.009_BIB8","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1155\/2001\/272394","article-title":"The application of protein microarrays to serum diagnostics: prostate cancer as a test case","volume":"17","author":"Miller","year":"2001","journal-title":"Dis. Markers"},{"key":"10.1016\/j.clim.2003.12.009_BIB9","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1126\/science.270.5235.484","article-title":"Serial analysis of gene expression","volume":"270","author":"Velculescu","year":"1995","journal-title":"Science"},{"key":"10.1016\/j.clim.2003.12.009_BIB10","doi-asserted-by":"crossref","first-page":"2871","DOI":"10.1021\/ac9810516","article-title":"Role of accurate mass measurement (\u00b110 ppm) in protein identification strategies employing MS or MS\/MS and database searching","volume":"71","author":"Clauser","year":"1999","journal-title":"Anal. Chem."},{"key":"10.1016\/j.clim.2003.12.009_BIB11","doi-asserted-by":"crossref","first-page":"10156","DOI":"10.1074\/jbc.M112230200","article-title":"Twists and turns of the cation-dependent mannose 6-phosphate receptor. Ligand-bound versus ligand-free receptor","volume":"277","author":"Olson","year":"2002","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.clim.2003.12.009_BIB12","doi-asserted-by":"crossref","first-page":"1287","DOI":"10.1016\/0006-291X(88)90769-3","article-title":"Mannose 6-phosphate\/insulin-like growth factor II receptor: distinct binding sites for mannose 6-phosphate and insulin-like growth factor II","volume":"150","author":"Braulke","year":"1988","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.clim.2003.12.009_BIB13","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1023\/A:1009571417429","article-title":"Mannose 6-phosphate\/insulin-like growth factor 2 receptor, a bona fide tumor suppressor gene or just a promising candidate?","volume":"5","author":"DaCosta","year":"2000","journal-title":"J. Mammary Gland Biol. Neoplasia"},{"key":"10.1016\/j.clim.2003.12.009_BIB14","first-page":"4314","article-title":"Altered ligand binding by insulin-like growth factor II\/mannose 6-phosphate receptors bearing missense mutations in human cancers","volume":"59","author":"Devi","year":"1999","journal-title":"Cancer Res."},{"key":"10.1016\/j.clim.2003.12.009_BIB15","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1046\/j.1365-2567.1999.00889.x","article-title":"Identification of cation-independent mannose 6-phosphate receptor\/insulin-like growth factor type-2 receptor as a novel target of autoantibodies","volume":"98","author":"Tarrago","year":"1999","journal-title":"Immunology"},{"key":"10.1016\/j.clim.2003.12.009_BIB16","doi-asserted-by":"crossref","first-page":"1725","DOI":"10.1002\/j.1460-2075.1985.tb03842.x","article-title":"Internalization of blocking antibodies against mannose-6-phosphate specific receptors","volume":"4","author":"Gartung","year":"1985","journal-title":"EMBO J."},{"key":"10.1016\/j.clim.2003.12.009_BIB17","doi-asserted-by":"crossref","first-page":"1281","DOI":"10.1002\/j.1460-2075.1984.tb01963.x","article-title":"Antibody to mannose 6-phosphate specific receptor induces receptor deficiency in human fibroblasts","volume":"3","author":"von Figura","year":"1984","journal-title":"EMBO J."},{"key":"10.1016\/j.clim.2003.12.009_BIB18","first-page":"368","article-title":"Evidence of determinant spreading in the antibody responses to prostate cell surface antigens in patients immunized with prostate-specific antigen","volume":"8","author":"Cavacini","year":"2002","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.clim.2003.12.009_BIB19","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1111\/j.1600-065X.1998.tb01208.x","article-title":"The functional significance of epitope spreading and its regulation by co-stimulatory molecules","volume":"164","author":"Vanderlugt","year":"1998","journal-title":"Immunol. Rev."},{"key":"10.1016\/j.clim.2003.12.009_BIB20","first-page":"844","article-title":"GVAX (Cell Genesys)","volume":"2","author":"Dummer","year":"2001","journal-title":"Curr. Opin. Investig. Drugs"},{"key":"10.1016\/j.clim.2003.12.009_BIB21","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1038\/73193","article-title":"Regression of human metastatic renal cell carcinoma after vaccination with tumor cell-dendritic cell hybrids","volume":"6","author":"Kugler","year":"2000","journal-title":"Nat. Med."},{"key":"10.1016\/j.clim.2003.12.009_BIB22","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1002\/jso.2930360313","article-title":"In vitro production of human antibodies specifically reactive with human gastric cancer cells of established lines and autologous tissues","volume":"36","author":"Takayama","year":"1987","journal-title":"J. Surg. Oncol."},{"key":"10.1016\/j.clim.2003.12.009_BIB23","first-page":"289","article-title":"Characterization of a MAb to ovarian cancer and its possible diagnostic application","volume":"20","author":"Salmassi","year":"1999","journal-title":"Eur. J. Gynaecol. Oncol."},{"key":"10.1016\/j.clim.2003.12.009_BIB24","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1007\/BF01742255","article-title":"IgM monoclonal antibody JD118 recognizes an inducible antigen target for human-complement-mediated cytotoxicity against neoplastic B cells","volume":"36","author":"Czuczman","year":"1993","journal-title":"Cancer Immunol. Immunother."},{"key":"10.1016\/j.clim.2003.12.009_BIB25","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1007\/BF00205648","article-title":"A monoclonal antibody with binding and inhibiting activity towards human pancreatic carcinoma cells. I. Immunohistological and immunochemical characterization of a murine monoclonal antibody selecting for well differentiated adenocarcinomas of the pancreas","volume":"23","author":"Bosslet","year":"1986","journal-title":"Cancer Immunol. Immunother."},{"key":"10.1016\/j.clim.2003.12.009_BIB26","first-page":"3614","article-title":"Altered expression in squamous carcinoma cells of an orientation restricted epithelial antigen detected by monoclonal antibody A9","volume":"46","author":"Kimmel","year":"1986","journal-title":"Cancer Res."}],"container-title":["Clinical Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521661603003504?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521661603003504?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,4,2]],"date-time":"2020-04-02T03:37:47Z","timestamp":1585798667000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1521661603003504"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,5]]},"references-count":26,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2004,5]]}},"alternative-id":["S1521661603003504"],"URL":"https:\/\/doi.org\/10.1016\/j.clim.2003.12.009","relation":{},"ISSN":["1521-6616"],"issn-type":[{"value":"1521-6616","type":"print"}],"subject":[],"published":{"date-parts":[[2004,5]]}}}